DAILY MORNING NOTE | 3 August 2023

Singapore stocks fell 1.4 per cent on Wednesday (Aug 2) amid broad selling across the region, after ratings agency Fitch downgraded the credit rating of the US. Shares of Singtel, which were trading ex-dividend led the decliners, sinking 6.8 per cent to S$2.46. Other counters that also saw heavy selling include Sats, which slid 3.2 per cent to S$2.73 and DFI Retail Group, which was down 2.3 per cent to US$2.58. Yangzijiang Shipbuilding was the top gainer after climbing 1.3 per cent to S$1.57.

Wall Street stocks dropped on Wednesday, joining a sea of red on global equity bourses. The Dow Jones Industrial Average shed almost 350 points, or 1.0 per cent, to finish at 35,282.52. The broad-based S&P 500 dropped 1.4 per cent to 4,513.39, while the tech-rich Nasdaq Composite Index tumbled 2.2 per cent to 13,973.45.

Top gainers & losers

Factsheets


EVENTS OF THE WEEK

Factsheets


SG

DBS’ 2Q2023 results beat expectations with net profit of S$2.69bn vs consensus estimate of S$2.39bn. Bulk of the beat was from stronger than expected net interest income of S$3.43bn (+40% YoY) and net interest margin growth to 2.16% (+58bps YoY). Fee income recovered and grew 7% YoY but fell 3% QoQ to S$768mn. Credit costs rose slightly by 2bps to 10bps as allowances were up 57% YoY to S$72mn mainly due to a rise in SPs to S$114mn (+65% YoY). 2Q23 dividend up 33% to 48 cents, bringing 1H23 dividend to 90 cents. More details to follow after 11.30am analyst call.

Glenn Thum
Senior Research Analyst
glennthumjc@phillip.com.sg


Great Eastern Holdings Limited reported its financial results for the half-year ended 30 June 2023 with the Group’s Total Weighted New Sales (“TWNS”) for 2Q23 and 1H23 declining 39% and 31% respectively against the same periods a year ago, reflecting lower single premium sales from the Singapore market. This was partially offset by growth in regular premium sales, particularly in protection plans and whole life plans through the Group’s core distribution channels. The Group’s New Business Embedded Value (“NBEV”) fell 9% for 2Q23 and 10% for 1H23 to S$181.5 million and S$351.2 million respectively. NBEV margin, however, has improved for 2Q23 and 1H23 due to more favourable product mix towards protection plans in Singapore and Malaysia. Across the Group, the total new customer base grew by over 150,000 in 1H23. The Board of Directors has declared an interim one-tier tax exempt dividend of 35 cents per ordinary share, to be paid on 31 August 2023.

CapitaLand Ascott Trust (CLAS) has announced plans to acquire three lodging assets from its sponsor at an agreed property value of S$530.8 million. It also intends to launch a fundraising exercise to raise at least S$300 million to partially fund the acquisition with the issue of new stapled securities. The three assets are The Cavendish London hotel in the UK, the Temple Bar Hotel in Dublin, Ireland, and the Ascott Kuningan Jakarta serviced residence in Indonesia. CLAS’ manager said on Wednesday (Aug 2) that it expects the proposed acquisition to raise its total distribution by S$13.5 million and its distribution per security by 1.8 per cent on a FY2022 pro forma basis. The equity fundraising comprises a private placement of between 187.8 million and 192.1 million new stapled securities within the proposed issue price range of S$1.041 to S$1.065, as well as a pro rata and non-renounceable preferential offering of up to 100.5 million new stapled securities at between S$1.025 and S$1.044. About S$170.2 million of the amount raised from this will go towards partially funding the acquisitions.

Keppel Corporation has disposed of another 50 million shares in Seatrium for a total consideration of S$7.26 million, or 14.52 cents each. The disposal, which amounts to a 0.07% stake in Seatrium, was done via the market on July 28. The recent disposal comes after Keppel sold some 42 million shares in Seatrium for S$5.17 million, or 12.3 cents each, on June 5. After the latest transaction, Keppel has an interest in 2.1496% of the shares in Seatrium.

A wholly-owned subsidiary of Catalist-listed Sanli Environmental Limited has proposed to divest its leasehold property at 28 Kian Teck Drive for S$4.95 million, owing to the group’s expansion. According to an Aug 2 bourse filing, Sanli M&E Engineering has granted an option to purchase to a company named Global Training Services. “The purchaser is an independent and unrelated third party and has duly exercised the option on Aug 2.” The property has leasehold tenure of 30 years commencing from Jan 1, 2012. The property comprises office and workshop space, with a gross floor area of approximately 1,982.4 sq m and is currently occupied by the Sanli Environmental group for its own use. Based on the property’s audited net asset value of approximately S$3.295 million as of March 31, the proposed disposal is expected to result in a gain on disposal of approximately S$1.655 million. The proposed disposal will result in a positive cash inflow of S$4.851 million, says the group.

OUE Limited and the manager of OUE Commercial REIT have unveiled a S$22 million asset enhancement initiative (AEI) for Crowne Plaza Changi Airport (CPCA), expected to complete by end-2023. Works include the addition of 12 guest rooms to a total room stock of 575 and repurposing a former restaurant space into a 352 sq m function room. In an Aug 2 statement, the manager of OUE C-REIT says it expects the AEI to be accretive to distribution per unit (DPU). “With the estimated capital expenditure of up to approximately S$14 million, the AEI is expected to generate a stabilised return on investment of approximately 10%.” The manager intends to draw down on existing loan facilities to fully fund the AEI, which is not expected to have a material effect on the net tangible assets or aggregate leverage of OUE C-REIT and its subsidiaries for the financial year ending Dec 31.

Shanghai-listed Milkyway Chemical, via its wholly-owned Singapore-incorporated subsidiary, Milkyway International Chemical Supply Chain, has made a firm offer of 22.66 cents per share for LHN Logistics. The offer price is said to be final. Milkway Chemical had previously made a pre-conditional offer offering the same amount for the shares in LHN Logistics on June 4. The deal was conditional upon LHN’s shareholders approving the sale and obtaining written consent from JTC for the change in LHN’s indirect ownership in Hean Nerng Logistics, LHN’s wholly-owned subsidiary. Hean Nerng Logistics owns the property located at 7 Gul Avenue. The offer comes after both conditions were fulfilled on July 31.


US

PayPal reported adj. earnings (US$1.16) and revenue (US$7.3bn) for the second quarter that was in line with analysts’ estimates. However, its shares fell 7 per cent in extended trading on Wednesday as investors were disappointed by the payments firm’s quarterly operating margin miss (adj. operating margin 21.4% vs est. 22%), which were mainly due to an increase in loans provisions. On the flip side, Total Active Accounts remained flat, with Total Payments Volume (TPV) growth of 11% YoY continuing to reflect resiliency in consumer spending. The company guided to US$7.4bn in revenue for 3Q23e (8% YoY), with adj. earnings of US$1.23 (14% YoY).

Jonathan Woo
Senior Research Analyst
jonathanwookj@phillip.com.sg


Shopify shares were little changed after the close as the company reported better-than-expected sales for 2Q23. The ecommerce infrastructure company reported Gross Merchandise Volume (GMV) up 17% YoY to US$55bn, an increase of US$8.2bn over the second quarter of 2022. Revenue increased 31% YoY to US$1.7bn, vs est. US$1.6bn, while adj. earnings was US$0.14 vs est. US$0.06. For the 3Q23e, Shopify is forecasting revenue to grow at a low-20% rate YoY, with Gross margin expected to be 2-3% higher than 2Q23 gross margin of 49.3%.

Jonathan Woo
Senior Research Analyst
jonathanwookj@phillip.com.sg


CVS Health on Wednesday reported second-quarter earnings and revenue that beat expectations, as the company slashes costs and lays off thousands of employees. CVS has implemented a cost-cutting program as it pushes deeper into health-care services in the wake of its US$8 billion acquisition of Signify Health and its US$10.6 billion purchase of Oak Street Health. Part of that effort calls for cutting 5,000 jobs. Earnings per share came in at US$2.21 adjusted, vs. US$2.11 expected while revenue was US$88.9 billion, vs. US$86.5 billion expected. The health-care giant posted net income of US$1.91 billion for the quarter, or US$1.48 per share, a 37% decline from the same period in 2022 when CVS reported net income of US$3.04 billion, or US$2.29 per share. CVS maintained its full-year adjusted earnings guidance of US$8.50 to US$8.70 per share, after slashing its projections by 20 cents last quarter due to costs associated with its recent acquisitions.

US ADP private payrolls increased more than expected in July, pointing to continued labor market resilience that could shield the economy from a recession. Private payrolls rose by 324,000 jobs last month, the ADP National Employment report showed on Wednesday. Data for June was revised lower to show 455,000 jobs added instead of the previously reported 497,000. Economists polled had forecast private employment would increase by 189,000.

Qualcomm reported third-quarter earnings on Wednesday that beat Wall Street expectations, but revenue and guidance for the fourth quarter came up short. Earnings was US$1.87 per share, adjusted, versus US$1.81 per share expected by consensus estimates while revenue came in at US$8.44 billion, adjusted, versus US$8.5 billion expected. Qualcomm said it expected earnings of between US$1.80 and US$2 per share on between US$8.1 billion and US$8.9 billion in sales in the fourth quarter, short of consensus expectations of US$1.91 in earnings on US$8.7 billion in revenue. Net income during the quarter fell to US$1.8 billion, or US$1.60 per share, a staggering 52% drop from the US$3.73 billion, or US$3.29 per share, reported a year earlier.

Unity Software Inc. raised its annual forecast and posted a narrower-than-expected loss. The company reported a second-quarter loss of US$201.2 million, or 51 cents a share, compared with US$205.8 million, or 69 cents a share, in the year-ago period. Unity did not readily break out an adjusted earnings-per-share figure. Revenue rose to US$533.5 million from US$297 million in the year-ago quarter. Analysts had forecast a second-quarter loss of 62 cents a share, adjusted earnings of 8 cents a share, and revenue of US$518 million for the second quarter. Unity forecast revenue of US$540 million to US$550 million for the third quarter, because of a flat game ads market and a continued soft market in China. For the year, Unity increased the low end of its annual outlook and now forecasts revenue of US$2.12 billion to US$2.2 billion for the year.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


RESEARCH REPORTS

Raffles Medical Group Ltd. – Margins still at record levels

Recommendation: BUY (Maintained); TP: S$1.76

Last Done: S$1.36; Analyst: Paul Chew

– 1H23 revenue and PATMI were within expectation at 49%/42% of our estimates. The jump in healthcare services earnings was higher than expected. PATMI was up a modest 0.5% YoY to S$59mn.

– Revenue for healthcare service was lower due to the absence of COVID-19-related services at the clinics. Hospital revenue is boosted by the return of foreign patients and transitional care facilities. Operating margins remain at record levels of around 21% despite losses in China.

– We maintain our FY23e forecast and BUY recommendation. Our DCF target price of S$1.76 is unchanged. We expect 2H23e earnings will be supported by price increases and a higher volume of foreign patients. However, the reduced contribution of COVID-19 services and lower margins from transitional care facilities (TCF) will place pressure on group margins.

PSR Stocks Coverage

Factsheets

Factsheets


For more information, please visit:

https://www.stocksbnb.com/singapore-stocks-coverage/


Upcoming Webinars

Guest Presentation by Audience Analytics

Date: 10 Aug 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/jz5w76fa


Guest Presentation by Paragon REIT

Date: 10 Aug 2023

Time: 3pm – 4pm

Register: https://tinyurl.com/3sx2tnp9


Guest Presentation by Prime US REIT

Date: 17 Aug 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/bdd9wp2a


Guest Presentation by Netlink NBN Trust

Date: 24 Aug 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/2hpm7puv


Guest Presentation by Uni-Asia Group Limited

Date: 30 Aug 2023

Time: 12pm – 1pm

Register: https://tinyurl.com/y5nhcvzn


Guest Presentation by Elite Commercial REIT

Date: 8 Sept 2023

Time: 7pm – 8pm

Register: https://tinyurl.com/544xs5v6


POEMS Podcast:

Research Videos

Weekly Market Outlook: Alphabet Inc, Spotify, Microsoft, UOB, CapitaLand Ascott, Keppel Corp & More
Date: 31 July 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.

PHILLIP RESEARCH IN 3 MINS

Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!

Disclaimer

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com